Collegium Pharmaceutical (COLL) Insider Trading & Ownership $29.75 +0.53 (+1.81%) (As of 11/19/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Collegium Pharmaceutical (NASDAQ:COLL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.98%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$6.62 M Get COLL Insider Trade Alerts Want to know when executives and insiders are buying or selling Collegium Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address COLL Insider Buying and Selling by Quarter Ad Colonial Metals“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! Collegium Pharmaceutical Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/13/2024Thomas B SmithEVPSell9,593$36.62$351,295.66 9/5/2024Shirley R KuhlmannEVPSell19,248$38.30$737,198.40 5/28/2024Colleen TupperCFOSell19,710$34.21$674,279.10 5/24/2024Scott DreyerEVPSell56,807$33.98$1,930,301.86 5/14/2024Garen G BohlinDirectorSell28,985$32.30$936,215.50 1/16/2024Scott DreyerEVPSell23,560$32.28$760,516.80 12/21/2023Joseph CiaffoniCEOSell4,357$30.38$132,365.66 12/19/2023Joseph CiaffoniCEOSell14,516$30.03$435,915.48 11/27/2023Shirley R KuhlmannEVPSell25,600$25.78$659,968.00 (Data available from 1/1/2013 forward) COLL Insider Trading Activity - Frequently Asked Questions Who is on Collegium Pharmaceutical's Insider Roster? The list of insiders at Collegium Pharmaceutical includes Colleen Tupper, Garen G Bohlin, Joseph Ciaffoni, Michael Thomas Heffernan, Scott Dreyer, Shirley R Kuhlmann, and Thomas B Smith. Learn more on insiders at COLL. What percentage of Collegium Pharmaceutical stock is owned by insiders? 3.98% of Collegium Pharmaceutical stock is owned by insiders. Learn more on COLL's insider holdings. Which Collegium Pharmaceutical insiders have been selling company stock? The following insiders have sold COLL shares in the last 24 months: Colleen Tupper ($1,426,361.90), Garen G Bohlin ($936,215.50), Joseph Ciaffoni ($4,222,368.40), Michael Thomas Heffernan ($1,869,314.79), Scott Dreyer ($3,535,042.72), Shirley R Kuhlmann ($2,374,058.56), and Thomas B Smith ($351,295.66). How much insider selling is happening at Collegium Pharmaceutical? Insiders have sold a total of 548,071 Collegium Pharmaceutical shares in the last 24 months for a total of $14,714,657.53 sold. Collegium Pharmaceutical Key ExecutivesMr. Michael Thomas Heffernan B.S. Pharm (Age 60)R.Ph., Co-Founder & Chairman Compensation: $110kMr. Joseph J. Ciaffoni (Age 52)President, CEO & Director Compensation: $1.69MMs. Colleen Tupper (Age 48)Executive VP & CFO Compensation: $848.29k1 recent tradesMs. Shirley R. Kuhlmann (Age 40)Executive VP, General Counsel, Chief Administrative Officer & Secretary Compensation: $842.9k1 recent tradesMr. Scott Dreyer (Age 52)Executive VP & Chief Commercial Officer Compensation: $746.58k1 recent tradesDr. Thomas B. Smith FAAFP (Age 63)M.D., Executive VP & Chief Medical Officer Compensation: $692.91kDr. Christopher Shayne James M.D.Vice President of Investor RelationsMr. Bart J. DunnExecutive Vice President of Strategy & Corporate DevelopmentMr. Scott SudduthHead of Technical Operations More Insider Trading Tools from MarketBeat Related Companies NKTR Insider Buying EGRX Insider Buying OGN Insider Buying RYTM Insider Buying APLS Insider Buying MRUS Insider Buying IBRX Insider Buying PTCT Insider Buying AGIO Insider Buying BHC Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:COLL) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredAmazon's $150B Data Center Bet—What It Means for Uranium InvestorsAmazon is placing a massive bet on nuclear energy to power its $150 billion data center expansion. With dem...The Bull Report | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | SponsoredThe Stock Powering Musk’s AI Revolution—RevealedImagine being able to invest in Tesla, PayPal, or SpaceX before the world knew their potential. Today, you ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Collegium Pharmaceutical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Collegium Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free COLL Stock Alerts